Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanocarrier and probe strategies for nuclear targeting.

International journal of pharmaceutics·2026
Same author

Design and synthesis of fluorescent calix[4]arene-1,8-Naphthalimide derivatives: Transparent biofilms, antioxidant and antimicrobial properties, and real-samples applications.

Food chemistry·2026
Same author

Advances in the designing endoplasmic reticulum-targeted fluorescent probes.

Bioorganic chemistry·2026
Same author

Design, synthesis, anticancer activity, bioimaging, and molecular docking of novel fluorescent isatin derivatives.

Investigational new drugs·2026
Same author

Advances in design of golgi apparatus-targeted fluorescent probes.

Journal of drug targeting·2025
Same author

Recent Advances in the Application of Mitochondria-targeted Fluorescent Probes.

Current medicinal chemistry·2025

Related Experiment Video

Updated: May 10, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Neonatal congenital heart block.

Ayse Yildirim1, F Sedef Tunaoolu, Aysu Turkmen Karaaoac

  • 1Departments of Pediatric cardiology, Pediatrician Kartal Kobuyolu Training and Research Heart Hospital, Itanbul, Turkey. ayildirimmd@yahoo.com

Indian Pediatrics
|June 20, 2013
PubMed
Summary

Congenital heart block (CHB) is linked to maternal autoantibodies, causing fetal heart conduction issues. Early echocardiographic surveillance and intrauterine treatments are crucial for managing this neonatal lupus complication.

More Related Videos

Noninvasive Electrocardiography in the Perinatal Mouse
04:36

Noninvasive Electrocardiography in the Perinatal Mouse

Published on: June 12, 2020

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Experiment Videos

Last Updated: May 10, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Noninvasive Electrocardiography in the Perinatal Mouse
04:36

Noninvasive Electrocardiography in the Perinatal Mouse

Published on: June 12, 2020

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Area of Science:

  • Immunology
  • Cardiology
  • Obstetrics

Background:

  • Congenital Heart Block (CHB) is a severe complication of neonatal lupus erythematosus.
  • Maternal anti-SSA/Ro or anti-SSB/La antibodies crossing the placenta around 12 weeks gestation cause CHB.
  • This leads to fetal heart conduction system inflammation, fibrosis, and scarring in the second trimester.

Purpose of the Study:

  • To highlight the association between maternal autoantibodies and CHB.
  • To emphasize the importance of early fetal echocardiographic surveillance.
  • To review intrauterine treatment options for CHB.

Main Methods:

  • Review of literature on CHB pathogenesis and management.
  • Fetal echocardiography for surveillance.
  • Intrauterine interventions including medications and pacing.

Main Results:

  • CHB diagnosis typically occurs between 18-24 weeks gestation.
  • First and second-degree atrioventricular (AV) blocks can vary, but third-degree AV block is irreversible.
  • Various intrauterine treatments show controversial efficacy.

Conclusions:

  • Maternal autoantibody-positive mothers require close fetal echocardiographic surveillance from the early second trimester.
  • Intrauterine treatments for CHB, though debated, include medications and pacing.
  • Aggressive medical treatment combined with pacing is used for non-responsive infants.